| News
New studies highlighted in the annual congress on the study of liver diseases

Between November 1-5, 2013, the 64th Annual Congress of the American Association for the Study of Liver Disease was held in Washington (USA)

| Treatments
Treatment of chronic hepatitis C with faldaprevir and deleobuvir

En agosto la revista New England Journal of Medicine publica un artículo sobre el tratamiento libre de interferón de la hepatitis crónica C con Faldaprevir (inhibidor de la proteasa del virus) y Deleobuvir (inhibidor de la polimerasa vírica).

| Hepatitis-C | News
New publication on Occult Hepatitis C

A new study by members of the Foundation for the Study of Viral Hepatitis on the presence of hidden hepatitis C in patients with chronic hepatitis B is published in the Journal of Medical Microbiology.

| Hepatitis-C
Latest news about hepatitis C

In January of this year two important studies of Hepatitis C treatment without interferon have been published. So Kowdley et al (NEJMed, 222-232) have used three inhibitory drugs from different areas of the C virus.

| Hepatitis-C
Therapeutic alternatives to control hepatitis C

Currently there are antiviral treatments against chronic hepatitis C (pegylated interferon + ribavirin + inhibitors) with a favorable response in 75% of cases. However, these treatments can have important side effects and contraindications for its administration.

1 8 9 10
Artículos destacados
Card image cap
Liver and diet (I)

27 de October de 2019

Ver más

About Us

The Foundation for the Study of Viral Hepatitis is a benchmark in the field of hepatology worldwide, with the best specialists in liver diseases and molecular biology. A clinic specialized in internal medicine, liver and digestive system in Madrid

© 2018 - 2023 FEHV Clinic. All rights reserved. Privacy and Cookies Policy.